These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26646436)

  • 1. Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia.
    Choi BR; Soni KK; Zhang LT; Lee SW; So I; Kim HK; Park JK
    Int J Urol; 2016 Mar; 23(3):259-65. PubMed ID: 26646436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model.
    Choi BR; Kim HK; Soni KK; Karna KK; Lee SW; So I; Park JK
    Drug Des Devel Ther; 2018; 12():1855-1863. PubMed ID: 29970959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
    Kobayashi S; Tomiyama Y; Tatemichi S; Hoyano Y; Kobayashi M; Yamazaki Y
    Eur J Pharmacol; 2009 Jun; 613(1-3):135-40. PubMed ID: 19389393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia].
    Tomiyama Y; Tatemichi S; Tadachi M; Kobayashi S; Hayashi M; Kobayashi M; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():225-30. PubMed ID: 16518087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
    J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia.
    Kang KK; Kim JM; Yu JY; Ahn BO; Yoo M; Kim YC
    Int J Urol; 2007 Oct; 14(10):946-51; discussion 951. PubMed ID: 17880297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
    Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
    Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.
    Tatemichi S; Akiyama K; Kobayashi M; Yamazaki Y; Yokoyama O; Uruno T
    J Urol; 2006 Sep; 176(3):1236-41. PubMed ID: 16890732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia.
    Ohtake A; Sato S; Saitoh C; Yuyama H; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Aug; 497(3):327-34. PubMed ID: 15336951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Chloro-7-trifluoromethyl-10H- benzo[4,5]furo[3,2-b]indole-1-carboxylic acid (TBIC), a putative BK(Ca) channel opener with uterine relaxant activities.
    Ahn HS; dela Peña I; Kim YC; Cheong JH
    Pharmacology; 2011; 87(5-6):331-40. PubMed ID: 21646818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Duration of action of silodosin (KMD-3213) against phenylephrine-induced increase in intraurethral pressure in rats].
    Kobayashi M; Tatemichi S; Kobayashi K; Imamura T; Maruyama I; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():231-6. PubMed ID: 16518088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder-relaxant properties of the novel benzofuroindole analogue LDD175.
    dela Peña IC; Yoon SY; Kim SM; Lee GS; Ryu JH; Park CS; Kim YC; Cheong JH
    Pharmacology; 2009; 83(6):367-78. PubMed ID: 19451752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
    Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On benzofuroindole analogues as smooth muscle relaxants.
    dela Peña I; Cheong JH
    J Biomed Biotechnol; 2011; 2011():389056. PubMed ID: 21941431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized rats.
    Yanai-Inamura H; Ohtake A; Noguchi Y; Hatanaka T; Suzuki M; Ueshima K; Sato S; Sasamata M
    Eur J Pharmacol; 2012 Mar; 679(1-3):127-31. PubMed ID: 22314219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
    Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
    Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.
    Nascimento-Viana JB; Carvalho AR; Nasciutti LE; Alcántara-Hernández R; Chagas-Silva F; Souza PA; Romeiro LA; García-Sáinz JA; Noël F; Silva CL
    J Pharmacol Exp Ther; 2016 Jan; 356(1):212-22. PubMed ID: 26493747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
    Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
    J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.